This invention is in the field of medicinal pharmacology. In particular, the present invention relates to pharmaceutical compositions comprising lactoferrin (e.g., naturally occurring lactoferrin, recombinant lactoferrin) which function as inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral entry into a subject (e.g., human subject). The invention further relates to methods of preventing, treating and/or ameliorating symptoms related to conditions caused by the SARS-CoV-2 virus (e.g., COVID-19), comprising administering to a subject (e.g., human subject) lactoferrin (e.g., naturally occurring lactoferrin, recombinant lactoferrin) (e.g., oral formulation of lactoferrin, intravenous (IV) formulation of lactoferrin) alone or with additional agents (e.g., remdesivir).

This invention is in the field of medicinal pharmacology. In particular, the present invention relates to pharmaceutical compositions comprising lactoferrin (e.g., naturally occurring lactoferrin, recombinant lactoferrin) which function as inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral entry into a subject (e.g., human subject). The invention further relates to methods of preventing, treating and/or ameliorating symptoms related to conditions caused by the SARS-CoV-2 virus (e.g., COVID-19), comprising administering to a subject (e.g., human subject) lactoferrin (e.g., naturally occurring lactoferrin, recombinant lactoferrin) (e.g., oral formulation of lactoferrin, intravenous (IV) formulation of lactoferrin) alone or with additional agents (e.g., remdesivir).

The present application provides lactoferrin, and compositions comprising lactoferrin, for use in the treatment and/or prevention of the 2019 novel coronavirus (COVID-19) infection in a subject.

The present disclosure features methods and compositions for enhancing the ability of the respiratory membranes to filter airborne pathogens and protect a subject from respiratory infections that result from inhalation or ingestion of such pathogens. In particular, the disclosure provides antimicrobial compositions that prevent and treat respiratory infections caused by bacteria, fungi, and viruses.

The present disclosure features methods and compositions for enhancing the ability of the respiratory membranes to filter airborne pathogens and protect a subject from respiratory infections that result from inhalation or ingestion of such pathogens. In particular, the disclosure provides antimicrobial compositions that prevent and treat respiratory infections caused by bacteria, fungi, and viruses.

The present disclosure features methods and compositions for enhancing the ability of the respiratory membranes to filter airborne pathogens and protect a subject from respiratory infections that result from inhalation or ingestion of such pathogens. In particular, the disclosure provides antimicrobial compositions that prevent and treat respiratory infections caused by bacteria, fungi, and viruses.

New formulation to be used in the treatment and prevention of infections caused by COVID-19 and other coronaviruses, consisting of a food supplement the main active ingredient of which is liposome-encapsulated lactoferrin. As secondary active ingredients, it includes zinc salt and vitamin C, also encapsulted in liposomes. This composition is intended to be used as a treatment for mild or acute cases of COVID-19, and to prevention infection by those who are not infected.

New formulation to be used in the treatment and prevention of infections caused by COVID-19 and other coronaviruses, consisting of a food supplement the main active ingredient of which is liposome-encapsulated lactoferrin. As secondary active ingredients, it includes zinc salt and vitamin C, also encapsulted in liposomes. This composition is intended to be used as a treatment for mild or acute cases of COVID-19, and to prevention infection by those who are not infected.

There is provided herein a composition for boosting the immune system comprising a keratin compound and beta-lactoglobulin (LGB).

There is provided herein a composition for boosting the immune system comprising a keratin compound and beta-lactoglobulin (LGB).